Fluoxetine: Key role and clinical applications of antidepressants

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) widely used to treat depression, anxiety and other mental disorders. This article will introduce its pharmacological mechanism, indications, common side effects and manufacturers, focusing on analyzing its core role in the field of mental health, supplemented by practical application cases and data support. The content structure is as follows: overview, principle of action, clinical application, precautions and market status.

Pharmacological mechanism and core functions

Fluoxetine improves mood regulation by inhibiting the reuptake of serotonin by neurons and increasing the concentration of this neurotransmitter in the synaptic cleft. Its long half-life (approximately 4-6 days) allows once-daily dosing, improving patient compliance. Studies have shown that the remission rate of fluoxetine for severe depression can reach 50%-70%, but individual differences need to be carefully evaluated. The U.S. FDA first approved it for the treatment of adult depression in 1987, and later expanded to include obsessive-compulsive disorder (OCD) and bulimia nervosa.

Indications and typical treatment options

The clinical applications of fluoxetine include:

Indications	Starting dose (mg/day)	Maximum dose (mg/day)
depression	20	80
obsessive-compulsive disorder	20	60
premenstrual dysphoric disorder	20	60

It should be noted that the efficacy usually takes 2-4 weeks to appear, and adverse reactions such as suicidal tendencies need to be closely monitored during this period. British NICE guidelines recommend it as a first-line treatment option for moderate to severe depression.

Safety and special population precautions

Common side effects include insomnia (about 15%), headache (12%) and gastrointestinal discomfort, most of which resolve within 1-2 weeks. It is prohibited to use it in combination with MAOI drugs as it may cause serotonin syndrome. Pregnant women need to weigh the risks when using it, and the FDA pregnancy classification is C. It is recommended that elderly patients start with 10 mg/day, and those with liver dysfunction need to reduce the dose. A 2019 "Lancet" study pointed out that the benefit-risk ratio of fluoxetine needs to be strictly evaluated in adolescent patients.

Market status and summary

The original drug is produced by Eli Lilly and Company (trade name Prozac), and there are dozens of generic drug companies around the world, including:

Manufacturer	Trade name	Listed area
Huahai Pharmaceutical	Yuk	China
Teva	Fluoxetine	Europe and America

As a classic SSRI, fluoxetine has proven its efficacy and safety in more than 30 years of use, but the principle of personalized medication needs to be emphasized. Future research may focus on new exploration of its anti-inflammatory effects and neuroprotective mechanisms.

Quote sources:
1. FDA drug instructions (Prozac, 2022 version)
2. National Institute for Health and Care Excellence (NICE) Depression Guidelines (2021)
3. "Lancet Psychiatry" 2019 SSRI Adolescent Study
4. Eli Lilly and Company Annual Drug Safety Report (2023)